Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Aspirin and Homocysteine

drug:

Aspirin

supplement:

Homocysteine

Research Papers that Mention the Interaction

Hcy levels significantly affected suboptimal response to ASA , but not to ADP-mediated aggregation.
Journal of cardiovascular pharmacology  •  2015  |  View Paper
Aspirin (more than 1 mg/l) had more effect on higher concentrations of homocysteine.
Aspirin increased velocity of clot lysis and decreased lysis time of clot in the presence of homocysteine.
Homocysteine at 50 &mgr;mol/l with aspirin (100, 10, and 1 mg/l) had significant changes in all fibrinolysis parameters (P < 0.05), compared to homocysteine at 50 &mgr;mol/l.
homocysteine … aspirin 100 ml/g had significant changes in the lysis maximum velocity (0.150 ± 0.002), half-lysis time (218 ± 5.77), the total lysis … time (278 ± 7.63), the total lysis time (515 ± 14.29), and lag time in lysis (176 ± 3.60), respectively (P < 0.05).
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis  •  2014  |  View Paper
Hcy diminished in vitro antiplatelet effect of low ASA concentration and augmented platelet aggregation (by up to 62% (p<0.005) for coll and up to 15% (p<0.005) for AA), whereas its acetyl derivative acted oppositely.
Otherwise, Hcy intensified antiplatelet action of high ASA.
Pharmacological research  •  2013  |  View Paper
There was a significant interaction between high tHcy and aspirin use (OR=0.57, 95% CI=0.36–0.91), but not between high tHcy and B-vitamin use (OR=0.80, 95% CI=0.26–2.46).
Translational Psychiatry  •  2012  |  View Paper
Conclusion Discordant results from MTHFR studies and randomised trials could be explained by aspirin reducing or negating the anti-platelet effect of lowering homocysteine.
PloS one  •  2011  |  View Paper
Proliferation‐induced homocysteine formation and in parallel also monocyte activation can be suppressed effectively by aspirin and salicylic acid in vitro, suggesting that also in vivo aspirin may downregulate not only inflammation but also formation of homocysteine.
Scandinavian journal of immunology  •  2005  |  View Paper
Acetylsalicylic acid totally prevented the effect of homocysteine on acetylcholinesterase activity and catalase activity and immunocontent, as well as the ultrastructural changes, and partially prevented alterations on IL-1β levels, superoxide dismutase activity, sulfhydryl content, and comet assay.
In summary, our findings showed that chronic chemically induced model of mild hyperhomocysteinemia altered some parameters and acetylsalicylic acid administration seemed to be neuroprotective, at least in part, on neurotoxicity of homocysteine.
Neurotoxicity Research  •  2017  |  View Paper